Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-vvkck Total loading time: 0 Render date: 2024-04-28T07:54:55.394Z Has data issue: false hasContentIssue false

Chapter 5 - The Inpatient with Dementia

Published online by Cambridge University Press:  05 March 2020

Michael I. Casher
Affiliation:
University of Michigan
Joshua D. Bess
Affiliation:
University of Michigan
Get access

Summary

Dementia, or Major Neurocognitive Disorder per the DSM-V, is an umbrella term used to describe a group of clinical syndromes defined by deterioration in intellectual functioning. In order to diagnose dementia, an individual must have a significant decline in cognitive functioning from baseline, with deficits in at least one cognitive domain. Common domains affected include reasoning ability, visual–spatial processing, mathematical ability, language, and executive function. As dementia progresses, individuals have increasing difficulties with the “4 As”: amnesia (inability to use or retain memory), aphasia (difficulty with receptive and/or expressive language), apraxia (loss of ability to perform previously learned tasks) and agnosia (misidentification of familiar people, objects, or places). In its later stages, basic functioning ceases and individuals become totally dependent on others for care.

The clinical syndrome of dementia can be caused by a number of different underlying disease processes, varying from nutritional deficiencies to neurodegenerative disorders.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Gurland, B. Epidemiology of psychiatric disorders. In: Sadavoy, J, Jarvik, L, Grossberg, G, Meyers, B, eds. Comprehensive textbook of geriatric psychiatry, third edition. New York, London: W.W. Norton & Co., Inc.; 2004: 1314.Google Scholar
Kales, HC, Gitlin, LN, Lyketsos, CG. Assessment and management of behavioral and psychological symptoms of dementia. BMJ 2015;350:h369.CrossRefGoogle ScholarPubMed
Conn, D. Other dementias and mental disorders due to general medical conditions. In: Sadavoy, J, Jarvik, L, Grossberg, G, Meyers, B, eds. Comprehensive textbook of geriatric psychiatry, third edition. New York, London: W.W. Norton & Co., Inc.; 2004: 545–79.Google Scholar
Almberg, B, Grafström, M, Winblad, B. Caring for a demented elderly person – burden and burnout among caregiving relatives. Journal of Advanced Nursing 1997;25(1):109–16.CrossRefGoogle ScholarPubMed
Knopman, D, Berg, J, Thomas, R, et al. Nursing home placement is related to dementia progression: experience from a clinical trial. Neurology 1999;52(4):714–18.Google Scholar
Smith, GE, O’Brien, PC, Ivnik, RJ, Kokmen, E, Tangalos, EG. Prospective analysis of risk factors for nursing home placement of dementia patients. Neurology 2001;57(8):1467–73.CrossRefGoogle ScholarPubMed
Kapp, M. Legal issues in dementia. International Journal of Risk and Safety in Medicine 2008;20(1):91103.CrossRefGoogle Scholar
Folstein, MF, Folstein, SE, McHugh, PR. “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975;12(3):189–98.Google ScholarPubMed
Nasreddine, ZS, Phillips, NA, Bedirian, V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society 2005;53(4):695–9.CrossRefGoogle Scholar
Feldman, HH, Jacova, C, Robillard, A, et al. Diagnosis and treatment of dementia: 2. Diagnosis. Canadian Medical Association Journal 2008;178(7):825–36.Google Scholar
Alagiakrishnan, K, Wiens, CA. An approach to drug induced delirium in the elderly. Postgraduate Medical Journal 2004;80(945):388–93.Google Scholar
Boyle, L, Ismail, M, Porsteinsson, A. The dementia work-up. In: Agronin, M, Maletta, G, eds. Principles and practice of geriatric psychiatry. Philadelphia: Lippincott Williams & Wilkins; 2004.Google Scholar
Baird, A. Fine tuning recommendations for older adults with memory complaints: using the Independent Living Scales with the Dementia Rating Scale. Clinical Neuropsychologist 2006;20(4):649–61.Google ScholarPubMed
Moore, D, Palmer, B, Patterson, T, Jeste, D. A review of performance-based measures of functional living skills. Journal of Psychiatric Research 2007;41(1–2):97118.CrossRefGoogle ScholarPubMed
Skelton, F, Kunik, M, Regev, T, Naik, A. Determining if an older adult can make and execute decisions to live safely at home: a capacity assessment and intervention model. Archives of Gerontology and Geriatrics 2009; 50(3): 300–5.Google Scholar
Raskind, M, Bonner, L, Peskind, E. Cognitive disorders. In: Blazer, D, Steffens, D, Busse, E, eds. The American Psychiatric Publishing textbook of geriatric psychiatry, 3rd ed. Washington DC: American Psychiatric Publishing, Inc.; 2004:207–29.Google Scholar
Weintraub, D, Hurtig, HI. Presentation and management of psychosis in Parkinson’s disease and dementia with Lewy bodies. American Journal of Psychiatry 2007;164(10):1491–8.Google Scholar
Wolf, PA, Clagett, GP, Easton, JD, et al. Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 1999;30(9):1991–4.CrossRefGoogle ScholarPubMed
Thomson, A, Marshall, E. The natural history and pathophysiology of Wernicke’s encephalopathy and Korsakoff’s psychosis. Alcohol and Alcoholism 2006;41(2):151–8.CrossRefGoogle ScholarPubMed
Sechi, G, Serra, A. Wernicke’s encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurology 2007;6(5):442–55.Google Scholar
Sadavoy, J, Lanctot, K, Deb, S. Management of behavioural and psychological symptoms of dementia and acquired brain injury. In: Tyrer, P, Silk, K, eds. Effective treatments in psychiatry. Cambridge: Cambridge University Press; 2008:187216.CrossRefGoogle Scholar
Kales, H, Gitlin, L, Lyketsos, C. Assessment and management of behavioral and psychological symptoms of dementia. BMJ 2015;305: h369.CrossRefGoogle Scholar
Livingston, G, Johnston, K, Katona, C, et al. Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia. American Journal of Psychiatry 2005;162(11):19962021.Google Scholar
Steinberg, M, Shao, H, Zandi, P, et al. Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study. International Journal of Geriatric Psychiatry 2008;23(23):170–7.CrossRefGoogle ScholarPubMed
Trinh, NH, Hoblyn, J, Mohanty, S, et al. Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer’s disease: a meta-analysis. JAMA 2003;289(2):210–15.CrossRefGoogle ScholarPubMed
Howard, RJ, Juszczak, E, Ballard, CG, et al. Donepezil for the treatment of agitation in Alzheimer’s disease. The New England Journal of Medicine 2007;357: 1382–92.Google Scholar
Wild, R, Pettit, T, Burns, A. Cholinesterase inhibitors for dementia with Lewy bodies. Cochrane Database of Systematic Reviews 2003;3: CD003672.Google Scholar
Jeste, DV, Blazer, D, Casey, D, et al. ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology 2007;33(5):957–70.Google ScholarPubMed
Schneider, L, Dagerman, K, Insel, P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005;294(15):1934–43.Google Scholar
Wang, P, Schneeweiss, S, Avorn, J, et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. The New England Journal of Medicine 2005;353(22):2335–41.Google Scholar
Tible, O, Riese, F, Savaskan, E, Guten, AV. Best practice in the management of behavioral and psychological symptoms of dementia. Therapeutic Advances in Neurological Disorders 2007;10(8): 297309.Google Scholar
Lopez, OL, Becker, JT, Chang, YF, et al. The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer’s disease. American Journal of Psychiatry 2013;170:1051–8.Google Scholar
Sultzer, DL, Davis, SM, Tariot, PN, et al. Clinical symptom responses to atypical antipsychotic medications in Alzheimer’s disease: phase 1 outcomes from the CATIE-AD effectiveness trial. American Journal of Psychiatry 2008;165:844–54.CrossRefGoogle ScholarPubMed
Schneider, LS, Dagerman, K, Insel, PS. Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. American Journal of Geriatric Psychiatry 2006;14(3):191210.CrossRefGoogle ScholarPubMed
Miller, B, Darby, A, Benson, D, Cummings, J, Miller, M. Aggressive, socially disruptive and antisocial behaviour associated with fronto-temporal dementia. British Journal of Psychiatry 1997;170(2):150–5.Google Scholar
Haussermann, P, Goecker, D, Beier, K, Schroeder, S. Low-dose cyproterone acetate treatment of sexual acting out in men with dementia. International Psychogeriatrics 2003;15(2):181–6.Google Scholar
Light, SA, Holroyd, S. The use of medroxyprogesterone acetate for the treatment of sexually inappropriate behaviour in patients with dementia. Journal of Psychiatry & Neuroscience 2006;31(2):132–4.Google Scholar
Alexopoulos, G. Late-life mood disorders. In: Sadavoy, J, Jarvik, L, Grossberg, G, Meyers, B, eds. Comprehensive textbook of geriatric psychiatry, third edition. New York, London: W.W. Norton & Co., Inc.; 2004: 616–17.Google Scholar
Lee, H, Lyketsos, C. Depression in Alzheimer’s disease: heterogeneity and related issues. Biological Psychiatry 2003;54(3):353–62.Google Scholar
Lyketsos, C, Olin, J. Depression in Alzheimer’s disease: overview and treatment. Biological Psychiatry 2002;52(3):243–52.Google Scholar
Lyketsos, C, DelCampo, L, Steinberg, M, et al. Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS. Archives of General Psychiatry 2003;60(7):737.Google Scholar
Raji, M, Brady, S. Mirtazapine for treatment of depression and comorbidities in Alzheimer disease. The Annals of Pharmacotherapy 2001;35(9):1024–7.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×